https://orcid.org/0000-0003-1505-1823
Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
J. Hoes, H. Pasmans, T. M. Schurink-van ’t Klooster, F. R. M. van der Klis, R. Donken, J. Berkhof & H. E. de Melker. (2022) Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Babban Jee, Renu Yadav, Sangeeta Pankaj & Shivendra Kumar Shahi. (2021) Immunology of HPV-mediated cervical cancer: current understanding. International Reviews of Immunology 40:5, pages 359-378.
Read now
Read now
Firzan Nainu, Rufika Shari Abidin, Muh. Akbar Bahar, Andri Frediansyah, Talha Bin Emran, Ali A Rabaan, Kuldeep Dhama & Harapan Harapan. (2020) SARS-CoV-2 reinfection and implications for vaccine development. Human Vaccines & Immunotherapeutics 16:12, pages 3061-3073.
Read now
Read now
Gregory D. Zimet & Nosayaba Osazuwa-Peters. (2019) There’s Much Yet to be Done: Diverse Perspectives on HPV Vaccination. Human Vaccines & Immunotherapeutics 15:7-8, pages 1459-1464.
Read now
Read now
Articles from other publishers (25)
Eric O. Mick, Meagan J. Sabatino, Matthew J. Alcusky, Frances E. Eanet, William S. Pearson & Arlene S. Ash. (2023) The role of primary care providers in testing for sexually transmitted infections in the MassHealth Medicaid program. PLOS ONE 18:11, pages e0295024.
Crossref
Crossref
Ling Han & Bingyi Zhang. (2023) Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect. Infectious Agents and Cancer 18:1.
Crossref
Crossref
Jaime Restrepo, Teobaldo Herrera, Rudiwilai Samakoses, Julio C. Reina, Punnee Pitisuttithum, Angels Ulied, Linda-Gail Bekker, Edson D. MoreiraJrJr, Sven-Eric Olsson, Stan L. Block, Luciano S. Hammes, Fabio Laginha, Alex Ferenczy, Robert Kurman, Brigitte M. Ronnett, Mark Stoler, Oliver Bautista, Nancy E. Gallagher, Gino Salituro, Min Ye & Alain Luxembourg. (2023) Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety. Pediatrics 152:4.
Crossref
Crossref
Merve ALDIKAÇTIOĞLU TALMAÇ, Nazlı Aylin VURAL, Zeliha Zeynep SATILMIŞOĞLU, Füreya Zilal HOCAGİL, Merve ATASOY RUSEN & Nilüfer ÇETİNKAYA. (2023) Knowledge level about HPV infection and cervical cancer screening testsHPV Enfeksiyonu ve Rahim Ağzı Kanseri Tarama Testleri Hakkında Bilgi Düzeyi. Journal of Contemporary Medicine 13:5, pages 949-953.
Crossref
Crossref
Cecilia Losada, Hady Samaha, Erin M. Scherer, Bahaa Kazzi, Lana Khalil, Ighovwerha Ofotokun & Nadine Rouphael. (2023) Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV. Vaccines 11:6, pages 1067.
Crossref
Crossref
Juan Shi, Yu Zhao, Min Peng, Suyue Zhu, Yandan Wu, Ruixue Ji & Chuanlai Shen. (2023) Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2. Vaccines 11:4, pages 713.
Crossref
Crossref
Vicky Roy, Wonyeong Jung, Caitlyn Linde, Emily Coates, Julie Ledgerwood, Pamela Costner, Galina Yamshchikov, Hendrik Streeck, Boris Juelg, Douglas A. Lauffenburger & Galit Alter. (2023) Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination. npj Vaccines 8:1.
Crossref
Crossref
Ojone Illah & Adeola Olaitan. (2023) Updates on HPV Vaccination. Diagnostics 13:2, pages 243.
Crossref
Crossref
Giancarlo Bessa. 2023. Dermatology in Public Health Environments. Dermatology in Public Health Environments
1501
1520
.
Ayazhan Akhatova, Azliyati Azizan, Kuralay Atageldiyeva, Aiymkul Ashimkhanova, Aizada Marat, Yerbolat Iztleuov, Assem Suleimenova, Saikal Shamkeeva & Gulzhanat Aimagambetova. (2022) Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State. Vaccines 10:11, pages 1912.
Crossref
Crossref
Chau Quang, Amy W. Chung, Ian H. Frazer, Zheng Quan Toh & Paul V. Licciardi. (2022) Single-dose HPV vaccine immunity: is there a role for non-neutralizing antibodies?. Trends in Immunology 43:10, pages 815-825.
Crossref
Crossref
Rahul Bhattacharjee, Lamha Kumar, Archna Dhasmana, Tamoghni Mitra, Abhijit Dey, Sumira Malik, Bonglee Kim & Rohit Gundamaraju. (2022) Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs. Frontiers in Oncology 12.
Crossref
Crossref
Xiyin Li, Lina Zhao, Ceshi Chen, Jianyun Nie & Baowei Jiao. (2022) Can EGFR be a therapeutic target in breast cancer?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:5, pages 188789.
Crossref
Crossref
Biagio Santella, Maria T. Schettino, Gianluigi Franci, Pasquale De Franciscis, Nicola Colacurci, Antonio Schiattarella & Massimiliano Galdiero. (2022) Microbiota and HPV: The role of viral infection on vaginal microbiota. Journal of Medical Virology 94:9, pages 4478-4484.
Crossref
Crossref
MannavaSai Priya, Atchyuta Mathi & Renuka Inuganti. (2022) Awareness and knowledge regarding human papilloma virus vaccine among medical students. Journal of Dr. NTR University of Health Sciences 11:3, pages 220.
Crossref
Crossref
Chi-Hong Duong, Judith E. Mueller, Pascale Tubert-Bitter & Sylvie Escolano. (2022) Estimation of mid-and long-term benefits and hypothetical risk of Guillain-Barre syndrome after human papillomavirus vaccination among boys in France: A simulation study. Vaccine 40:2, pages 359-363.
Crossref
Crossref
Sevil ALKAN & Hatice ÖNTÜRK AKYÜZ. (2021) SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU ÖĞRENCİLERİNİN HUMAN PAPİLLOMA VİRÜS ENFEKSİYONU/ AŞILAMASI HAKKINDA BİLGİ DÜZEYLERİNİN VE AŞILANMA DURUMLARININ BELİRLENMESİ: BİTLİS ÖRNEĞİDetermining the level of knowledge and vaccination status of Health Services Vocational School students about Human Papilloma Virus infection/vaccination: Bitlis Example. ANKEM Dergisi 35:3, pages 63-69.
Crossref
Crossref
Conor Hennessy & Declan P. McKernan. (2021) Anti-Viral Pattern Recognition Receptors as Therapeutic Targets. Cells 10:9, pages 2258.
Crossref
Crossref
Margaret Stanley, Elmar Joura, Glorian P. Yen, Smita Kothari, Alain Luxembourg, Alfred Saah, Anuj Walia, Gonzalo Perez, Hanane Khoury, Danielle Badgley & Darron R. Brown. (2021) Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines. Vaccine 39:16, pages 2214-2223.
Crossref
Crossref
Barbara J. Kuter, Suzanne M. Garland, Anna R. Giuliano & Margaret A. Stanley. (2021) Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What's ongoing, what's needed?. Preventive Medicine 144, pages 106321.
Crossref
Crossref
Naghmeh Hadidi, Zarin Sharifnia, Atefeh Eteghadi, Mohammad Ali Shokrgozar & Nariman Mosaffa. (2021) PEGylated single-walled carbon nanotubes as co-adjuvants enhance expression of maturation markers in monocyte-derived dendritic cells. Nanomedicine 16:3, pages 171-188.
Crossref
Crossref
Chengxue Zhong, Li Xu, Ho-Lan Peng, Samantha Tam, Li Xu, Kristina R. Dahlstrom, Chi-Fang Wu, Shuangshuang Fu, Wenyaw Chan, Erich M. Sturgis, Lois M. Ramondetta, Libin Rong, David R. Lairson & Hongyu Miao. (2021) An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas. Scientific Reports 11:1.
Crossref
Crossref
Lea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged & Aneesh Thakur. (2020) The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies. Frontiers in Immunology 11.
Crossref
Crossref
Liqin Cheng, Yan Wang & Juan Du. (2020) Human Papillomavirus Vaccines: An Updated Review. Vaccines 8:3, pages 391.
Crossref
Crossref
Marcello Guido, Annarita Bruno, Luigi Tagliaferro, Valerio Aprile, Andrea Tinelli, Alberto Fedele, Giambattista Lobreglio, Paola Menegazzi, Giancarlo Pasanisi, Vittorio Tassi, Bruno Forcina, Francesca Fortunato, Laura Isabella Lupo & Antonella Zizza. (2020) Universal Human Papillomavirus Vaccination and its Impact on the Southern Italian Region. Current Pharmaceutical Design 26:3, pages 343-357.
Crossref
Crossref